Kratos Selloff Confirms DeepValue's Cautious Stance

What happened

Kratos reported Q1'26 revenue of $371M, up 22.6%, with a 1.6x book-to-bill and record $2B backlog, but Q2 guidance points to limited organic growth. The 50% selloff from highs reflects market recognition of persistent cash consumption and valuation risk at 92.3x EV/EBITDA. Management explicitly states investments to scale production (including Valkyrie) will pressure margins and free cash flow through at least FY27. Despite the strong demand signals, the Feb. 2026 equity raise diluted shareholders, and free cash flow remained negative at -$8.6M in Q1. The stock now trades near $57.90, aligning with the DeepValue report's framework that the ramp is priced for perfection without near-term profit delivery.

Implication

Current holders should assess position size relative to the $48 attractive entry. The next two quarters must show funded backlog above $1.46B and improving cash conversion; if not, exit signals intensify.

Thesis delta

The news article validates the DeepValue report's concerns without altering its core thesis. The selloff aligns with the report's view that the valuation priced in a near-term inflection that management's guidance delays. The wait-and-see stance remains appropriate, with key milestones unchanged.